JBIO peer analysis
Jade Biosciences (JBIO) against its competitors: price, today's move, 1-year return and market value side by side.
JBIO and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACRS Aclaris Therapeutics | $4.25 | 8.97% | 87.22% | $674.10M |
| CTNM Contineum Therapeutics | $10.26 | 7.77% | -6.81% | $402.87M |
| DWTX Dogwood Therapeutics | $1.28 | 23.08% | -75.38% | $48.93M |
| ELDN Eledon Pharmaceuticals | $2.86 | 9.79% | -30.24% | $232.41M |
| KYTX Kyverna Therapeutics | $5.17 | 5.94% | -27.08% | $319.73M |
| MLTX MoonLake | $12.65 | 9.71% | 22.93% | $1.08B |
| REVB Revelation Biosciences | $3.89 | 9.27% | -86.24% | $2.21M |
| TRAX First Tracks Biotherapeutics | $49.99 | 4.36% | – | $2.10B |
| VERA Vera Therapeutics | $30.60 | 2.74% | 21.33% | $2.21B |
| JBIO Jade Biosciences | $15.60 | 3.48% | 74.25% | $991.80M |
- JBIO's peers: ACRS (Aclaris Therapeutics), CTNM (Contineum Therapeutics), DWTX (Dogwood Therapeutics), ELDN (Eledon Pharmaceuticals), KYTX (Kyverna Therapeutics), MLTX (MoonLake), REVB (Revelation Biosciences), TRAX (First Tracks Biotherapeutics).
Updated 2026-11-10 04:46 UTC